The WASF3-NCKAP1-CYFIP1 Complex Is Essential for Breast Cancer Metastasis

Area of Science:

• Molecular oncology
• Cancer cell biology
• Drug discovery

Background:

• The WASF3 gene is crucial for breast cancer cell invasion and metastasis.
• WASF3 function is modulated by a protein complex involving NCKAP1 and CYFIP1.
• Understanding the regulation of WASF3 is key to developing anti-metastasis therapies.

Purpose of the Study:

• To investigate the role of NCKAP1 in regulating the WASF3 complex and cancer cell invasion.
• To explore the potential of targeting the NCKAP1-CYFIP1 interaction for cancer therapy.

Main Methods:

• Silencing of NCKAP1 in cancer cell lines (breast, prostate, colon).
• In vivo metastasis model in immunocompromised mice.
• Stapled peptides and small molecules (WANT3) to disrupt the NCKAP1-CYFIP1 complex.
• Analysis of RAC1 binding to the WASF3 complex.

Main Results:

• Silencing NCKAP1 destabilized the WASF3 complex, suppressing invasion in multiple cancer types.
• Loss of NCKAP1 reduced spontaneous metastasis in an in vivo mouse model.
• NCKAP1 inactivation prevented RAC1 association with WASF3, inhibiting invasive capacity.
• Stapled peptides targeting NCKAP1-CYFIP1 disrupted the complex, suppressed RAC1 binding, and reduced invasion.
• The compound WANT3 demonstrated proof of concept for targeting this interaction.

Conclusions:

• WASF3 requires NCKAP1 for promoting cancer invasion and metastasis.
• Targeting the NCKAP1-CYFIP1 interface represents a novel strategy to inhibit cancer metastasis.
• The compound WANT3 shows promise as a therapeutic agent against breast cancer metastasis.